Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
3928studies shown
Showing 1,376-1,400 of 3,928
Active Not RecruitingNCT03684447

Neural and Antidepressant Effects of Propofol

This study is looking at compare the antidepressant effects of propofol at two different doses while measuring potential treatment-related biomarkers for people with Treatment Resistant Depression. Participants receive a study treatment and complete follow-up visits and assessments.

DepressionDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
University of Utah
Condition
Depression
RecruitingNCT06941298

Neural and Psychiatric Consequences of Cannabis Use in Adolescents

This study is looking at care and outcomes for people with Cannabis Use or Depression. Taking part may give some people access to Neuroimaging Investigation, but direct benefit is not guaranteed.

DepressionOtherFrom 14 Years to 20 Years
Countries
United States
Sponsor
University of Miami
Condition
Depression
RecruitingNCT04964206

Neuraxial Labor Analgesia and Offspring Neurodevelopment

This study is looking at explore the potential impact of maternal neuraxial labor analgesia exposure on offspring neurodevelopment for people with depression. Participants are followed over time so researchers can learn from clinical and follow-up information.

DepressionProcedureFrom 18 Years to 35 Years
Countries
China
Sponsor
Dong-Xin Wang
Condition
Depression
RecruitingNCT05712772

Neuro-affective Response to Light in Depressed Adolescents and Young Adults

This study is looking at whether questionnaires and follow-up can help people with Depression in Adolescence or Depression in. Participants receive a study treatment and complete follow-up visits and assessments.

DepressionOtherFrom 12 Years to 30 Years
Countries
United States
Sponsor
University of Pittsburgh
Condition
Depression
RecruitingNCT05570812

Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV

This study is looking at determine the effects of pregnenolone on brain function, inflammation and depressive symptoms in people with HIV who have depression for people with depression, anxiety or depression, or Hiv. Participants receive Placebo or placebo and complete study visits and assessments.

DepressionDrugFrom 18 Years to 85 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Depression
RecruitingNCT06695767

Neurobehavioral Therapy For Epilepsy And Major Depressive Disorder

This study is looking at whether Neurobehavioral therapy can help people with depression or Epilepsy. Participants take part in Neurobehavioral therapy and complete follow-up assessments.

DepressionBehavioralOver 18 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Depression
RecruitingNCT07328373

Neurobiological and Genomic Predictors of Relapse in Depression

This observational study is following people with Healthy or depression to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

DepressionOtherFrom 18 Years to 65 Years
Countries
Turkey
Sponsor
Mehmet Kemal Arikan
Condition
Depression
RecruitingNCT02543983

Neurobiology of Suicide

This study is looking at whether a digital support tool can help people with Depression. Participants receive a study treatment and complete follow-up visits and assessments.

DepressionOtherFrom 18 Years to 70 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Depression
Not Yet RecruitingNCT05139862

Neurocardiac Predictors of Treatment Response to RTMS in Depression

This study is looking at care and outcomes for people with Depression or Treatment Resistant Depression. Taking part may give some people access to Repetitive Transcranial Magnetic Stimulation, but direct benefit is not guaranteed.

DepressionDeviceFrom 19 Years to 65 Years
Countries
Canada
Sponsor
University of British Columbia
Condition
Depression
Not Yet RecruitingNCT07369115

Neurocircuitry Mechanisms and Efficacy of Lumateperone as Adjunctive Therapy for Major Depressive Disorder and History of Early Life Abuse

This study is comparing Lumateperone 42 mg with placebo for people with Major Depressive Diorder or Early Life Trauma. Participants receive Lumateperone 42 mg or placebo and complete study visits and assessments.

DepressionOtherFrom 21 Years to 70 Years
Countries
United States
Sponsor
University of Texas at Austin
Condition
Depression
Active Not RecruitingNCT05174273

Neurocognitive Effects of FMT in MDD Patients With and Without IBS

This study is looking at care and outcomes for people with depression or Irritable Bowel Syndrome. Some participants may receive Healthy Controls instead of the study treatment, and direct benefit is not guaranteed.

DepressionOtherFrom 18 Years to 60 Years
Countries
Canada
Sponsor
Valerie Taylor
Condition
Depression
RecruitingNCT05809115

Neurodevelopmental Outcomes in Children: Strengthening the Caregiver-Child Story

This observational study is following people with Food Insecurity, Depression, or Anxiety to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

AnxietyOtherOver 18 Years
Countries
United States
Sponsor
Baylor College of Medicine
Condition
Anxiety
UnknownNCT05936697

Neurofeedback Training For Older Adults

This study is comparing fNIRS with Sham Group for people with Depression, Anxiety. Participants receive fNIRS or Sham Group and complete study visits and assessments.

DepressionDeviceFrom 60 Years to 79 Years
Countries
China
Sponsor
The Hong Kong Polytechnic University
Condition
Depression
RecruitingNCT07159061

Neurofeedback to Treat Depression - 2

This study is comparing Active Closed Loop Real Time fMRI Neurofeedback with Sham Comparator: Sham Neurofeedback for people with depression. Participants receive Active Closed Loop Real Time fMRI Neurofeedback or Sham Comparator: Sham Neurofeedback and complete study visits and assessments.

DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Pennsylvania
Condition
Depression
RecruitingNCT07111169

Neuromodulation and Attention Deficits in MDD

This study is looking at whether a digital support tool can help people with Major Depression Disorder, Cognitive Deficits, or Selective Attention. Participants take part in a digital support tool and complete follow-up assessments.

DepressionOtherFrom 18 Years to 55 Years
Countries
China
Sponsor
University of Electronic Science and Technology of China
Condition
Depression
RecruitingNCT06129890

Neuromodulation in Patients With Neuropathic Pain and Depression.

This study is looking at care and outcomes for people with Neuropathic Pain or Depression. Taking part may give some people access to Repetitive transcranial magnetic stimulation (rTMS) - M1/DLPFC, but direct benefit is not guaranteed.

DepressionDeviceFrom 18 Years to 85 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Condition
Depression
RecruitingNCT04783103

Neuromodulation in the Elderly Depressed: a Brain Imaging Pilot Study

This study is looking at care and outcomes for people with Old Age or depression, Treatment-Resistant. Some participants may receive Sham adTMS instead of the study treatment, and direct benefit is not guaranteed.

DepressionDeviceOver 65 Years
Countries
Belgium
Sponsor
Universitair Ziekenhuis Brussel
Condition
Depression
RecruitingNCT06112652

Neuromodulation of Different Doses to Treat TRD Guided by pBFS Technique

This study is comparing 4 session rTMS with sham rTMS for people with Moderate Depression, depression, or Severe Depression. Participants receive 4 session rTMS or sham rTMS and complete study visits and assessments.

DepressionDeviceFrom 18 Years to 65 Years
Countries
China
Sponsor
Changping Laboratory
Condition
Depression
Depression | Clinical Trials | HopeStage Research